ImmunoCellular Therapeutics, Ltd. is a development stage company that is seeking to develop and commercialize therapeutics to fight cancer using the immune system. The Company?s product candidate portfolio includes peptide based cellular immunotherapies targeting cancer stem cells, cellular immunotherapies targeting cancer antigens and monoclonal antibodies to diagnose and treat different cancers. As of December 31, 2008, the products under development include ICT-121, ICT-107, ICT-109, ICT-037, ICT-69 and ICT-Diagnostic-SCLC. In February 2008, the Company acquired certain monoclonal antibody related technology owned by Molecular Discoveries LLC (Molecular Discoveries).

GainersToday is a Financial Web Site that provides to investors and traders, stock market recommendations, rankings and financial news. GainersToday keeps track of more than 20,000 recommendations given by more than 200 Research Companies.

At GainersToday smart investors can instantly find and compare thousands of
stocks recommendations. You can see past performance of Research Companies,
Accuracy, Percentage Gains.

You can add alerts by stock or by Research Company when a new stock
recommendation is released.